BARCLAYS PLC - PIERIS PHARMACEUTICALS INC ownership

PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 61 filers reported holding PIERIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of PIERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$10.0%5,006
-14.4%
0.00%
Q2 2023$1
-97.3%
5,849
-84.7%
0.00%
Q1 2023$37
-5.1%
38,195
+2.5%
0.00%
Q4 2022$39
-99.9%
37,2510.0%0.00%
Q3 2022$43,000
-38.6%
37,2510.0%0.00%
Q2 2022$70,000
-70.5%
37,251
-52.2%
0.00%
Q1 2022$237,000
-59.7%
77,954
-50.0%
0.00%
Q4 2021$588,000
+181.3%
155,908
+286.5%
0.00%
Q3 2021$209,000
+770.8%
40,339
+523.0%
0.00%
Q2 2021$24,000
-78.9%
6,475
-85.4%
0.00%
Q1 2021$114,000
+11.8%
44,373
+9.2%
0.00%
Q4 2020$102,000
+5.2%
40,629
-12.5%
0.00%
Q3 2020$97,000
-38.6%
46,446
-8.9%
0.00%
Q2 2020$158,000
+77.5%
50,972
+30.7%
0.00%
Q1 2020$89,000
-48.6%
39,005
-18.8%
0.00%
Q4 2019$173,000
+1.8%
48,007
-3.3%
0.00%
Q3 2019$170,000
-31.7%
49,666
-6.2%
0.00%
Q2 2019$249,000
+398.0%
52,952
+251.9%
0.00%
Q1 2019$50,000
+233.3%
15,047
+172.7%
0.00%
Q4 2018$15,000
-86.2%
5,517
-71.7%
0.00%
Q3 2018$109,000
+445.0%
19,464
+411.8%
0.00%
Q2 2018$20,000
-90.2%
3,803
-87.3%
0.00%
Q1 2018$204,000
+270.9%
29,858
+311.2%
0.00%
Q4 2017$55,000
-73.2%
7,261
-79.5%
0.00%
Q3 2017$205,00035,452
+131203.7%
0.00%
Q2 2017$0270.00%
Other shareholders
PIERIS PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Lynx1 Capital Management LP 9,775,849$2,913,2031.93%
Aquilo Capital Management, LLC 3,303,190$984,3510.89%
CM Management, LLC 649,400$193,5210.20%
BVF INC/IL 20,609,863$6,141,7390.17%
WEALTH EFFECTS LLC 11,700$3,4870.00%
NJ State Employees Deferred Compensation Plan 30,000$8,9400.00%
HUDSON VALLEY INVESTMENT ADVISORS INC /ADV 14,000$4,1720.00%
ACADIAN ASSET MANAGEMENT LLC 962,358$2860.00%
TWO SIGMA ADVISERS, LP 24,400$7,2710.00%
Tower View Wealth Management LLC 1,000$00.00%
View complete list of PIERIS PHARMACEUTICALS INC shareholders